Eli Lilly and Company (NYSE: LLY) today announced detailed results from the QWINT-5 phase 3 trial evaluating once-weekly ...

Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical ...

New research published in New England Journal of Medicine and presented at this year's Annual Meeting of the European ...

A new study highlights promising results for a once-weekly insulin injection in managing blood sugar levels for people with ...

People with type 1 or type 2 diabetes could soon benefit from weekly insulin injections after new research showed they are as effective at controlling blood sugar levels as daily jabs of long-acting ...

Eli Lilly’s experimental insulin that is injected just once a week is as effective as daily insulin injections for ...

The late-stage clinical trial results showed that Eli Lilly’s once-weekly insulin efsitora matched daily injections for ...

Clinical trials of a new, once-a-week insulin have shown that it controls blood sugar as well as daily injections of an ...

The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...

Implanting a pouch of stem-cell-derived pancreas cells under the skin of type 1 diabetics has enabled them to live without ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

New research published in NEJM and presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid (9-13 Sept) shows that a new class of insulin that is ...